AGS, NCI-N87, MKN-45 and Hs746T cells in a serum-free medium were transfected with miRNA mimics/siRNA/plasmid using lipofectamine 2000 reagent (Invitrogen, Carlsbad, USA).
For stable silencing UBAP2L, pRNAH1.1 vector containing shUBAP2L sequence or negative control (NC) was transfected into AGS and NCI-N87 cells. Forty-eight hours later, the cells were treated with G418 (400 μg/ml for AGS cells and 300 μg/ml for NCI-N87 cells) for 6 weeks until the monoclonal cell masses appeared. The cells stably silencing UBAP2L were cultured for subsequent experiments.
For the enhanced expression of UBAP2L, the UBAP2L overexpression plasmid, or pcDNA3.1 empty vector was transfected into MKN-45 and Hs746T cells.
To continuously express β-catenin, the overexpression plasmid generated from wild-type β-catenin with mutation of Ser33 to Tyr in pcDNA3.1 vector was transfected into UBAP2L-silenced AGS cells.